Danesi, V.; Massa, I.; Foca, F.; Delmonte, A.; Crinò, L.; Bronte, G.; Ragonesi, M.; Maltoni, R.; Manunta, S.; Cravero, P.;
et al. Real-World Outcomes and Treatments Patterns Prior and after the Introduction of First-Line Immunotherapy for the Treatment of Metastatic Non-Small Cell Lung Cancer. Cancers 2022, 14, 4481.
https://doi.org/10.3390/cancers14184481
AMA Style
Danesi V, Massa I, Foca F, Delmonte A, Crinò L, Bronte G, Ragonesi M, Maltoni R, Manunta S, Cravero P,
et al. Real-World Outcomes and Treatments Patterns Prior and after the Introduction of First-Line Immunotherapy for the Treatment of Metastatic Non-Small Cell Lung Cancer. Cancers. 2022; 14(18):4481.
https://doi.org/10.3390/cancers14184481
Chicago/Turabian Style
Danesi, Valentina, Ilaria Massa, Flavia Foca, Angelo Delmonte, Lucio Crinò, Giuseppe Bronte, Maria Ragonesi, Roberta Maltoni, Silvia Manunta, Paola Cravero,
and et al. 2022. "Real-World Outcomes and Treatments Patterns Prior and after the Introduction of First-Line Immunotherapy for the Treatment of Metastatic Non-Small Cell Lung Cancer" Cancers 14, no. 18: 4481.
https://doi.org/10.3390/cancers14184481
APA Style
Danesi, V., Massa, I., Foca, F., Delmonte, A., Crinò, L., Bronte, G., Ragonesi, M., Maltoni, R., Manunta, S., Cravero, P., Andrikou, K., Priano, I., Balzi, W., Gentili, N., Burke, T., & Altini, M.
(2022). Real-World Outcomes and Treatments Patterns Prior and after the Introduction of First-Line Immunotherapy for the Treatment of Metastatic Non-Small Cell Lung Cancer. Cancers, 14(18), 4481.
https://doi.org/10.3390/cancers14184481
